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ABSTRACT 
 
Objective: To examine the relationship between Mediterranean diet and risk of later-onset 
Crohn’s disease (CD) or ulcerative colitis (UC).  
Design: We conducted a prospective cohort study of 83,147 participants (age range: 45-79 years) 
enrolled in the Cohort of Swedish Men (CoSM) and Swedish Mammography Cohort (SMC). A 
validated food frequency questionnaire was used to calculate an adherence score to a modified 
Mediterranean diet (mMED) at baseline in 1997. Incident diagnoses of CD and UC were 
ascertained from the Swedish Patient Register. We used Cox proportional hazards modeling to 
calculate hazard ratios (HRs) and 95% CI. 
Results: Through December of 2017, we confirmed 164 incident cases of CD and 395 incident 
cases of UC with an average follow up of 17 years. Higher mMED score was associated with a 
lower risk of CD (Ptrend = 0.03) but not UC (Ptrend =0.61). Compared to participants in the lowest 
category of mMED score (0-2), there was a statistically significant lower risk of CD (HR = 0.42, 
95% CI 0.22-0.80) but not UC (HR = 1.08, 95% CI 0.74-1.58). These associations were not modified 
by age, sex, education level, body mass index, or smoking (All Pinteraction > 0.30). The prevalence 
of poor adherence to a Mediterranean diet (mMED score = 0-2) was 27% in our cohorts, 
conferring a population attributable risk of  12% for later-onset CD.  
Conclusion: In two prospective studies, greater adherence to a Mediterranean diet was 
associated with a significantly lower risk of later-onset CD.  
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What is already known about the topic: 
Diet is widely thought to play an important role in the pathogenesis of inflammatory bowel 
disease.  
Several epidemiologic studies have identified fiber intake to be protective against Crohn’s 
disease.  
 
What are the new findings: 
Greater adherence to a Mediterranean diet is associated with a lower risk of later onset Crohn’s 
disease.   
In two large prospective cohorts in Sweden, poor adherence to a Mediterranean diet conferred 
a population attributable risk of 12% for later-onset Crohn’s disease.  
How might it impact on clinical practice in the foreseeable future? 
Our findings further highlight the importance of continued research focusing on the benefits of 
the Mediterranean diet among individuals at risk of developing Crohn’s disease.  
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INTRODUCTION:  
 
The pathogenesis of Crohn’s disease (CD) and ulcerative colitis (UC), collectively known as 
inflammatory bowel disease (IBD), is thought to be related to an inappropriate immune response 
to the gut microbiota in a genetically susceptible host. Diet, through its interaction with the gut 
microbiome and host barrier function and immunity, plays an important role in the pathogenesis 
of IBD1. There are also accumulating data on the effectiveness of dietary strategies such as 
exclusive enteral nutrition (EEN) and the CD Exclusion Diet (CDED) in treatment of active CD1-4, 
further highlighting the critical role of diet in IBD. Nevertheless, prior epidemiologic studies of 
the relationship between diet and IBD have yielded very few plausible causal relationships 
(reviewed in 5). The majority of these studies have focused on individual food groups and 
nutrients. In contrast, studies that focus on characterizing the link between dietary patterns and 
risk of IBD can take into account overall eating patterns which represent the totality of all foods 
and beverages consumed, therefore preserving the complexities and potential for synergism 
between dietary components.  
 Recently, the Crohn’s and Colitis Foundation has undertaken an initiative to study the 
therapeutic effectiveness of Mediterranean diet in patients with established IBD.  However, the 
relationship between adherence to a Mediterranean diet, characterized by high intakes of fruit 
and vegetables, whole grains, polyunsaturated fat, and proteins from fish, legumes, and nuts, 
and incident IBD has not been widely explored. Several lines of evidence suggest a role for 
Mediterranean diet in both prevention and treatment of IBD. First, ecologic studies have 
demonstrated lower incidence of IBD in Southern Europe where there is a higher consumption 
of a Mediterranean diet (reviewed in 6). Second, previous studies have shown that  a 
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Mediterranean diet reduces plasma levels of inflammatory markers, such as high sensitivity C-
reactive protein and tumor necrosis factor alpha and the risk of development and progression of 
other immune-mediated disorders including psoriasis and rheumatoid arthritis7-10. Since IBD is 
characterized by a subclinical disease state marked by elevation in inflammatory and serological 
markers11, 12, adherence to a Mediterranean diet may have a plausible benefit in preventing 
development of clinically significant disease. Third, at least one small pilot study (n = 8) has 
demonstrated improvement in inflammatory markers, gene expression, and the gut microbiome 
in CD patients who consume a Mediterranean diet for 6 weeks13. Lastly, CDED has been shown 
to have therapeutic benefits in patients with CD1, and is comprised of components (i.e. high 
intake of fruit and vegetables and low intake of red and processed meat) that overlap with 
Mediterranean diet. 
We therefore sought to investigate the association between relative adherence to a 
Mediterranean diet and risk of incident CD and UC in two large prospective cohorts of men and 
women in Sweden. With detailed and validated data on dietary information on over 80,000 
middle-aged men and women, these cohorts offered us a unique opportunity to examine the 
relationship between diet and later-onset IBD, where relative to younger-onset disease the 
overall contribution of environment is significantly greater14, 15.  
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METHODS: 
Study population:  
Swedish Mammography Cohort (SMC) is a population-based prospective cohort study 
established between 1987 and 1990  in the Uppsala county of central Sweden.  Briefly, all women 
who lived in Uppsala County and were born from 1914 and 1948 received an invitation by mail 
to participate in a mammography screening program. A total of  66,651 women (74% response 
rate), age 40-74 years, returned completed questionnaires on diet, alcohol, weight, height, and 
reproductive and menopausal factors.  Additional data on other lifestyle factors (e.g. smoking, 
physical activity, etc.), medications, and medical illnesses were collected in  1997, 2008, and 
2009. Cohort of Swedish Men (CoSM) is a parallel prospective cohort of 45,906 men, age 45-79 
years, established in Örebro and Västmanland Counties in Central Sweden in the autumn of 1997.  
Similar to SMC, all men born between 1918 and 1952 in these counties received an invitation to 
participate in this study. Similar to SMC, participants provided information on diet and lifestyle 
factors (e.g. physical activity, smoking, etc) at baseline in 1997. Follow up questionnaires were 
administered in 2008 and 2009.  Our study population included participants who had completed 
the 1997 questionnaires in both cohorts, which included all participants in CoSM and women in 
SMC who were still alive in 1997 and returned the dietary questionnaire (n = 38,984, 70% 
response rate). We excluded participants with a diagnosis of IBD prior to baseline, who did not 
provide information on diet or had implausible total caloric intake defined by intakes not within 
three standard diviations of the log transformed mean (Figure 1).   
Primary Exposure and Other Covariates: 
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In both cohorts, dietary data were collected using a 96-item semiquantitative food frequency 
questionnaire (SFFQ) at baseline in 1997 (validation studies described below) as previously 
described16. Participants reported average frequency of consumption of each food item in the 
previous year.  There were 8 categories for frequency of intake ranging from zero servings per 
month to up to three times per day. Serving sizes for frequently consumed food groups (e.g. 
bread, coffee, tea, etc.) were prespecified. For other food groups, serving frequency was 
converted to average daily intake based on age‐ and sex‐specific portion sizes and reference data 
from the Swedish National Food Agency database17.  
 We calculated a modified Mediterranean diet score (mMED score), ranging from 0 to 8, 
based on relative adherence to a traditional Mediterranean diet adapted from a diet scale 
originally reported by Trichopoulou and colleagues18, 19.  One point was given for intakes above 
the median for (1) fruit and vegetables (apple, banana, berry, orange/citrus, and other fruit; 
carrot, beetroot, broccoli, cabbage, cauliflower, lettuce, onion, garlic, pepper, spinach, tomato, 
and other vegetables); (2) legumes (beans, pea soup, and lentils) and nuts; (3) non‐refined or 
high‐fiber grains (whole meal bread, crisp bread, oatmeal, and wheat bran); (4) fermented dairy 
products (cultured milk, yogurt, and cheese); and (5) fish. Additionally, one point was given for 
(6) intakes below the median of red and processed meat, for (7) use of olive or rapeseed oil for 
cooking or as dressing, and for (8) moderate alcohol consumption with an average of 5 to 15 
grams of alcohol per day. 
The SFFQ has been validated against fourteen 24-hr diet recall interviews conducted over 
a one-year period in a subset of participants in CoSM (n = 248). The Spearman coefficient 
correlations between SFFQ and fourteen 24-hr recall interview ranged between 0.70 to 0.81 for 
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intakes of total carbohydrate, fat, fiber, and alcohol20. Additionally, the reproducibility of two 
SFFQ completed one year apart was good with intraclass correlation ranging from 0.65 to 0.85 
for all macronutrients. In SMC, the SFFQ (version from 1987 similar to that used in CoSM and 
SMC in 1997) has been validated against four one-week diet records done over a one-year period 
in 129 women21. The Spearman correlation coefficient between SFFQ and diet records for ranged 
from 0.63 to 0.73 comparing dietary patterns (i.e. prudent versus western) and 0.40 to 0.82 for 
main food groups in a Mediterranean diet. Additionally, the reproducibility of these patterns 
between two SFFQ completed one year apart ranged from 0.41 to 0.73, consistent with other 
studies in Asia and the US22-24. Validated data on weight, height, and physical activity and detailed 
information on smoking and education level were also collected at baseline in both cohorts as 
previously described25-30. Lastly, information on date of death and emigration was collected from 
the Swedish Total Population Register31.   
Outcome Ascertainment:  
 The Swedish Patient Register has collected nationwide data on hospital discharges since 
198732. Each entry represents an encounter and includes date of birth, sex, dates of hospital 
admission, hospital department, and discharge diagnoses (including surgical procedures)32. All 
encounters are organized according to individual’s personal identify number. Starting in January 
of 2001, the Swedish Patient Register also included data on all non-primary care outpatient 
diagnoses and procedures33.  
 Incident cases of CD and UC were ascertained through linkage of SMC and CoSM 
participants to the Swedish Patient Register and were defined by at least two inpatient or 
outpatient encounters with a primary or secondary diagnosis (for UC ICD9: ‘556’ or ICD10: ‘K51’; 
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for CD ICD9: 555 or ICD10: K50) following the return of baseline questionnaires in 1997 in both 
cohorts. Use of ICD coding for identifying a number of chronic diseases, including IBD, in the 
inpatient component of the Swedish Patient Register has a positive predictive value of 85-95%34. 
Additionally, in a recent validation study designed specifically for IBD, using both inpatient and 
outpatient components of the Swedish Patient Register, the positive predictive values using our 
definition for CD, UC, and IBD cases were 81%, 90%, and 93% respectively35. 
Statistical Analysis: 
Follow up time was defined from January 1, 1998 to date of diagnosis, emigration, death, 
or end of follow up (December 31, 2017), whichever came first. We assessed the mMED score as 
a quantitative exposure and categorized as 0-2, 3-4, 5, and 6-8. These categories were selected a 
priori to reflect extreme scores and to ensure an adequate number of participants in each group 
based on prior studies of mMED score in these cohorts36, 37. The cutoffs for the lower and upper 
categories also correspond to the lower and upper quartiles of the mMED score distribution. 
Additionally, we examined for non-linear associations between mMED score and risk of CD and 
UC using restricted cubic splines38 and observed no evidence for such associations. We also used 
multiple imputations with chain equations to carry out 20 imputations of missing data on 
covariates. The proportion of missing data in our study was 9495 (11%) for physical activity, 2969 
(3.5%) for BMI, 1306 (1.5%) for smoking, and 182 (0.2%) for education level.   
We used Cox proportional hazards modeling to estimate the age- and multivariable (MV)-
adjusted hazard ratio (HR) and 95% confidence interval (CI). Our models were adjusted for age, 
body mass index (BMI), education level, smoking, total caloric intake, and physical activity (Met-
hr/week).  Additionally, all models were stratified by sex (i.e. cohort). Test for trend across 
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categories was conducted by assigning the median value to each mMED category and modeling 
this as a continuous variable. We performed several sensitivity analyses. We restricted our follow 
up to after January 2002 to account for the introduction of outpatient encounters in the Swedish 
Patient Register and to allow for one year gap for identifying prevalent cases of IBD previously 
not captured through inpatient register. In addition, this analysis allowed us to assess for the 
possibility of reverse causation related to participants’ dietary changes as a result of symptoms 
related to undiagnosed subclinical or early disease. We also examined the possibility that the 
association between Mediterranean diet and risk of IBD may differ according to subgroups 
defined by age, sex, BMI, and smoking. We tested for the significance of the interaction by 
entering mMED score and these covariates in our models as multiplicative interaction terms. 
Finally, we calculated the population attributable risk conferred by a relatively poor adherence 
to the Mediterranean diet (i.e. mMED score = 0-2), to estimate the percentage of IBD cases that 
might have been prevented if all participants had followed a Mediterranean diet, assuming a 
causal relationship39, 40.  We used SAS version 9.4 (Cary, NC) for these analyses. P-values were 2-
sided and values less than 0.05 were considered statistically significant. The study was approved 
by the regional ethics committee of Stockholm, Sweden. In both cohorts, consent to participate 
in the study was obtained through returned questionnaires.  
  
 12 
RESULTS: 
After exclusions, 83,147 participants were eligible for our analyses. Through December of 2017, 
we confirmed 164 incident cases of CD and 395 incident cases of UC, yielding an incidence rate 
of 12 cases/100,000 person-years and 28 cases/100,000 person-years for CD and UC, 
respectively. The mean follow up time of participants was 17 years (std = 5). The age at diagnosis 
of CD and UC ranged from 47 to 83 years. Baseline characteristics of participants are reported in 
Table 1. Compared to participants in the lowest category of mMED score, those in the highest 
category on average had a higher caloric intake and education level and were more likely to be 
female and  have never smoked. There were no significant differences in age, BMI, or physical 
activity.  
 In our age-adjusted model, we found that a higher mMED score was associated with a 
lower risk of CD (Ptrend = 0.02) (Table 2). Specifically, compared to participants in the lowest 
category of mMED score, the age-adjusted HRs of CD were 0.70 (95% CI 0.49-0.99), 0.78 (95% CI 
0.50-1.23), and 0.42 (95% CI 0.22-0.78) for participants with a mMED score of 3-4, 5, and 6-8, 
respectively. These associations were not altered after adjusting for potential confounders 
including education level, BMI, total caloric intake, smoking, physical activity, and cohort (sex) 
(Ptrend = 0.03). The MV-adjusted HRs were 0.69 (95% CI 0.48-0.99), 0.78 (95% CI 0.49-1.24), and 
0.42 (95% CI 0.22-0.80) for participants with a mMED score of 3-4, 5, and 6-8, respectively. We 
estimated that for every one-unit increase in mMED score, the MV-adjusted HR of CD was 0.87 
(95% CI 0.78-0.96). Overall, the prevalence of relatively poor adherence to a Mediterranean diet 
(i.e. mMED. Score = 0-2) was 27% at baseline, conferring an adjusted population attributable risk 
of 12% (95% CI 3-26%) for later-onset CD, assuming a causal relationship between diet and CD. 
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In contrast, we did not observe an association between mMED score and risk of UC (Ptrend =0.61). 
Compared to participants in the lowest category of mMED score, the MV-adjusted HRs of UC 
were 1.35 (95% CI 1.04-1.76), 1.37 (95% CI 0.99-1.90), and 1.08 (95% CI 0.74-1.58) for participants 
with a mMED score of 3-4, 5, and 6-8, respectively.  
 In exploratory analyses, we examined the association between individual components of 
mMED score and risk of CD and UC (Figure 2). Compared to participants with below the median 
consumption of nuts and legumes, the MV-adjusted HR of CD among participants with above the 
median consumption was 0.70, (95% CI 0.50-0.98). Higher consumption (above the median) of 
fruit and vegetable (MV-adjusted HR =0.83, 95% CI 0.60-1.15), fermented dairy (MV-adjusted HR 
= 0.82, 95% CI-0.59-1.13), and non-refined grains (MV-adjusted HR =0.78, 95% CI 0.55-1.10) and 
use of olive oil (MV-adjusted HR =0.70, 95% CI 0.50-0.98) were also associated with decreased 
risk of CD, albeit most estimates did not reach statistical significance. In contrast, we did not 
observe an association between any of the components of mMED score and risk of UC. We 
explored whether the association between mMED score and risk of CD and UC were consistent 
across several subgroups defined by age, sex (cohort), smoking, physical activity, or BMI (Tables 
3 and 4) and observed no evidence for effect modification (All Pinteraction > 0.50).   
 We conducted several sensitivity analyses. First, restricting our follow up to after January 
1, 2002 to account for dietary changes that might have resulted from subclinical or undiagnosed 
disease (i.e. excluding cases of CD and UC that were diagnosed within 4 years of SFFQ 
administration) did not materially alter our effect estimates. Specifically, compared to 
participants in the lowest category of mMED score, the MV-adjusted HRs of CD and UC in the 
highest category of mMED score were 0.44 (95% CI 0.23-0.84) and 1.14 (95% CI 0.77-1.69), 
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respectively. Second, because of the potential differential effect of fruit and vegetables on risk 
of IBD, we recalculated mMED score by separating these two food groups. Compared to 
participants in the lowest category of mMED score (0-2), the MV-adjusted HRs in the highest 
group of mMED group (7-9) were 0.57 (95% CI 0.32-0.99) for CD and 1.01 (95% CI 0.70 – 1.46) for 
UC. Third, as rapeseed oil was not included in the original definition of adherence to a 
Mediterranean diet, we conducted a sensitivity analysis excluding this from our calculation of 
mMED score. Compared to participants in the lowest category of mMED score (0-2), the MV-
adjusted HRs in the highest group of mMED group (6-8) were 0.44 (95% CI 0.23-0.85) for CD and 
1.07 (95% CI 0.73 – 1.57) for UC.  Finally, using a previously described array-based approach, we 
estimated that an unmeasured confounder would need to have a prevalence of 80% in the 
highest quartile of mMED score compared to 20% in the lowest quartile with a relative risk for 
CD of less than 0.17 to account for our observed association41.  
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DISCUSSION:  
In two large prospective cohorts of middle-aged men and women in Sweden, we demonstrate 
that greater adherence to a Mediterranean diet is inversely associated with risk of later-onset 
CD but not UC. These findings were consistent across multiple sensitivity and subgroup 
analyses.  
 To our knowledge, this is the first prospective cohort study that has examined the 
relationship between a Mediterranean diet and risk of incident CD and UC. Nevertheless, one 
prior study from the EPIC investigators did not show an association between a Mediterranean 
dietary pattern and risk of CD42. However, smaller numbers of CD cases and significant 
heterogeneity in methods used to collect dietary information across centers in EPIC-IBD’s 
nested case-control design may have limited the power of the study to find a significant 
association. Additionally, the influence of a Mediterranean diet on risk of CD may not be as 
pronounced in populations that are largely adherent to such a diet.  In contrast, several prior 
studies have shown a relationship between individual food groups and nutrients, found in high 
quantity in a Mediterranean diet and risk of IBD43, 44. One prior study from the US prospective 
cohort studies of the Nurses’ Health Study (NHS) and NHSII found that higher intake of fiber 
particularly from cruciferous vegetables and cereals is associated with a decreased risk of 
incident CD43.  Similarly, data from the European Prospective Cohort Study into Cancer and Diet 
(EPIC) have shown an inverse association between fiber derived from cereals and risk of CD 
among non-smokers44.  
 Our findings have plausible biologic mechanisms.  Several dietary intervention studies 
have demonstrated significant changes in inflammatory markers, immune cell populations, and 
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response to oxidative stress with Mediterranean diet8, 45. Specifically, in Healthy Lifestyle in 
Europe by Nutrition in Adolescence (HELENA) study, adherence to a Mediterranean diet was 
associated with an attenuation in oxidative stress response in adolescents45. Similarly, in the 
randomized controlled trial of European Project on Nutrition in Elderly People (NU-AGE), 
adherence to a Mediterranean diet for one year was associated with significant changes in 
innate and adaptive immunity as measured by T cell degranulation, cytokine production, and 
co-receptor expression8. These results are further supported by a number of cross sectional 
analyses of patients with immune-mediated disorders including CD and psoriasis demonstrating 
an inverse relationship between adherence to a Mediterranean diet and disease activity9, 46.  
Additionally, adherence to a Mediterranean diet appears to have significant beneficial effect on 
the gut microbiome composition and function47, 48. Lastly, components of a Mediterranean diet 
such as fiber may also exert anti-inflammatory effect through modification of the barrier 
function and bacterial translocation (reviewed in 49).  
Our observation that the beneficial association of the Mediterranean diet appears to be 
exclusive to CD is in line with prior studies demonstrating that diet appears to be a stronger 
modifiable lifestyle factor for CD50. Additionally, dietary intervention studies such as EEN and 
CDED have primarily been effective in CD1-4. Although the exact biologic rationale behind this 
unique relationship is unclear, it may be explained in part by the greater role of the gut 
microbiome in CD; specifically, CD is characterized by significant dysbiosis and further by 
improvement in disease activity with fecal diversion, as compared to UC51-53. Therefore, diet-
induced changes in the gut microbiome may have a greater impact in preventing and treating 
CD.  
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 We highlight several strengths of our study. First, the prospective nature minimized the 
risk of selection and recall biases that are commonly observed in cross-sectional studies of diet 
in IBD. Second, in our study we were able to account for other important lifestyle factors such 
as BMI, physical activity, and smoking that are likely to confound the relationship between diet 
and IBD. Lastly, we used a nationwide registry and a validated method to ascertain cases of CD 
and UC minimizing the risk of outcome misclassification. 
 We acknowledge several limitations. First, our study population included mostly middle-
aged men and women and therefore it is unclear whether our findings may be generalizable to 
younger individuals at risk of IBD.  Nevertheless, environmental factors may play a greater role 
in  development of later-onset IBD15, highlighting the importance of identifying modifiable risk 
factors in elderly-onset disease.  Further, many of the beneficial anti-inflammatory, immunologic, 
and metabolic effects of Mediterranean diet have specifically been demonstrated in older 
adults8. Second, calculation of mMED score was based on the distribution of dietary intake in our 
cohorts, which may not be generalizable to other populations with a vastly different pattern of 
dietary intake. As an example, comparing the median intake of the components of aMED score 
to those published by Trichopoulou and colleagues18 showed similar consumption of fruit and 
vegetable, red and processed meat, fish, and alcohol but vastly different intakes of legumes, nuts, 
and grains. Third, there are measurement errors associated with collection of dietary data. 
However, as demonstrated in our prior validation studies, when compared to other methods, 
SFFQ provides reasonably valid estimates of dietary intake.  Additionally, measurement error for 
diet is unlikely to be systematically associated with the outcome and therefore commonly results 
in a spurious under-estimate of associations, rather than false over-estimates54. Hence, the 
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inverse association with CD may be greater than we detected. Fourth, we do not have updated 
dietary data. However, as has been shown in other studies, individuals’ dietary intake remains 
relatively stable over time55 and therefore it’s  less likely that their categorization based on diet 
will significantly change over time . Lastly, we acknowledge that our observed associations may 
be related to residual confounding related to our inability to adjust for other factors such as 
family history of IBD and early life exposures. However, adjusting for known confounders did not 
materially alter our estimates. Additionally, in our sensitivity analysis, we demonstrated that it 
will be very unlikely for an unmeasured confounder to fully attenuate the observed association 
between mMED score and risk of CD.  
Conclusion: 
In two large prospective cohort studies, we show that a greater adherence to a 
Mediterranean diet is associated with a lower risk of later onset CD. Our study further 
highlights the importance of continued research focusing on the benefits of the Mediterranean 
diet in patients with established CD. Such efforts including the ongoing clinical trial of Specific 
Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease (DINE-CD) will 
provide significant insight into the role of diet in IBD therapeutics.  
 
Figure 1: Flow Chart of eligible participants in the study 
*Abbreviations: Cohort of Swedish Men (CoSM) and Swedish Mammography Cohort (SMC) 
 
 
Figure 2: The Association Between Adherence to Individual Components of mMED Score and 
Risk of CD and UC* 
*For fruit and vegetables, legumes & nuts, non-refined/high fiber grains, fermented dairy, and fish the estimates 
represent comparison of above the median consumption, representing a score = 1 for mMED score to below the 
median consumption. For red & processed meat, the estimate represents comparison of below the median 
consumption, representing a score = 1 for mMED score to above the median consumption. Moderate alcohol 
consumption is defined as 5-15 g of consumption per day.   
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Table 1: Baseline characteristics of participants in the Swedish Mammography Study (SMC) and Cohort of Swedish 
Men (CoSM) according to mMED score* 
 
mMED score 
(0-2) 
(n =22,237) 
(3-4) 
(n =36,951) 
(5) 
(n =13,630) 
(6-8) 
(n =10,329) 
Age (yrs) 62 (10) 61 (10) 61(9) 60 (9) 
     
Sex (female), % 36 45 53 61 
     
Education, %     
Primary school 80 73 65 57 
High school 10 11 12 13 
University 10 16 23 30 
     
Body Mass Index (kg/m2) 26 (4) 26 (4) 25 (3) 25 (3) 
     
Ever smoking, % 60 55 52 49 
     
Physical activity (Met-hr/wk) 42(5) 42(5) 42(5) 42(5) 
     
Total caloric intake 2038 (795) 2256(848) 2367 (847) 2411(783) 
     
Components of mMED score     
Fruit and vegetables (g/day) 251 (156) 386 (223) 492 (231) 557 (225) 
Legumes & nuts (g/day), 0.3 (1) 0.8 (2) 1 (3) 2(4) 
Non-refined/high fiber grains (g/day) 137 (115) 190 (131) 210 (128) 221 (121) 
Fermented dairy (g/day) 151 (182) 253 (240) 325 (260) 376 (256) 
Fish (g/day) 26 (29) 37 (37) 43 (33) 48 (30) 
Red & processed meat (g/day) 83 (55) 78 (56) 73 (51) 62 (43) 
Olive oil and/or rapeseed oil use, % 10 35 63 85 
Moderate alcohol intake, % 14 29 42 61 
*Abbreviations: years (yrs), standard deviation (std), Met-hours/week (Met-hr/wk), modified Mediterranean diet score (mMED 
score). All characteristics were derived from the 1997 questionnaires. Unless notes, continuous variables are presented in mean 
(standard deviation). 
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Table 2: mMED score and Risk of Crohn’s Disease and Ulcerative Colitis* 
 mMED score  
 (0-2) 
(n =22,237) 
(3-4) 
(n = 36,951) 
(5) 
(n = 13,630) 
(6-8) 
(n =10,329) 
 
     Ptrend¶ 
Person-years of follow up 361,082 624,597 238,698 185,790  
      
Crohn’s disease      
Number of cases 56 67 29 12  
Age-adjusted, HR (95% CI)  1.0 0.70 (0.49-0.99) 0.78 (0.50-1.23) 0.42 (0.22-0.78) 0.02 
MV-adjusted, HR (95% CI) ∆ 1.0 0.69 (0.48-0.99) 0.78 (0.49-1.24) 0.42 (0.22-0.80) 0.03 
      
      
Ulcerative colitis      
Number of cases 84 193 74 44  
Age-adjusted, HR (95% CI)  1.0 1.34 (1.03-1.73) 1.33 (0.98-1.82) 1.02 (0.71-1.46) 0.81 
MV-adjusted, HR (95% CI) ∆ 1.0 1.35 (1.04-1.76) 1.37 (0.99-1.90) 1.08 (0.74-1.58) 0.61 
*Abbreviations: Multivariable (MV), hazard ratio (HR), confidence intervals (CI). ∆ Models are adjusted for cohort (sex), age (years), education 
(primary school, high school, and education), body mass index, smoking (never, past, and current), and total caloric intake. ¶ Ptrend was 
calculated using the median value for each category.  
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Table 3: mMED Score and Risk of Crohn’s Disease According to Selected Strata* 
 Cases Person-years  MV-adjusted HR, 95% CI∆ Pinteraction 
Sex     
• Male 
• Female 
 99 
 65 
749,531 
660,637 
0.32 (0.11-0.89) 
0.50 (0.21-1.21) 
0.78 
Age at Start of Follow up     
• < 60 years 
• ≥ 60 years 
 101  
63 
773,622 
636,546 
0.45 (0.21-0.97) 
0.31 (0.09-1.07) 
0.84 
Body mass index¶     
• < 25 kg/m2 
• ≥ 25 kg/m2 
 79 
 85 
677,777 
732,391 
0.32 (0.13-0.79) 
0.56 (0.22-1.38) 
0.52 
Education     
• Primary school 
• High school 
• University 
120 
20 
24 
979,353 
162,981 
267,834 
0.45 (0.20-1.02) 
0.49 (0.09-2.57) 
0.46 (0.11-1.99) 
0.99 
Physical activity¶     
• < median 
• ≥ median 
 77 
 56 
547,956 
558,895 
0.33 (0.13-0.83) 
0.61 (0.21-1.78) 
0.82 
Smoking¶      
• Never smoker 
• Ever smoker 
 60 
 101 
623,266 
765,627 
0.83 (0.35-1.95) 
0.17 (0.05-0.57) 
0.55 
*Abbreviations: Multivariable (MV), hazard ratio (HR), confidence intervals (CI). ∆ Comparing the extremes of mMED score quartiles. 
Models are adjusted for age (years), cohort (sex), body mass index, smoking (never, past, and current), and total caloric intake. ¶ Missing 
data on these variables were not included or imputed for these analyses.  
 
 
 
 
 
 
  
 22 
Table 4: mMED Score and Risk of Ulcerative Colitis According to Selected Strata* 
 Cases Person-years  MV-adjusted HR, 95% CI∆ Pinteraction 
Sex     
• Male 
• Female 
 252 
 143 
749,531 
660,637 
1.20 (0.74-1.96) 
0.98 (0.52-1.84) 
 0.57 
Age at Start of Follow up     
• < 60 years 
• ≥ 60 years 
 247 
 148 
773,622 
636,546 
0.96 (0.59-1.57) 
1.32 (0.73-2.41) 
 0.85 
Body mass index¶     
• < 25 kg/m2 
• ≥ 25 kg/m2 
 173 
 222 
677,777 
732,391 
1.10 (0.63-1.93) 
1.09 (0.65-1.84) 
 0.97 
Education     
• Primary school 
• High school 
• University 
278 
42 
75 
979,353 
162,981 
267,834 
1.25 (0.79-1.99) 
1.71 (0.37-7.89) 
0.77 (0.35-1.71) 
0.37 
Physical activity¶       
• < below the median 
• ≥ below the median 
168 
157 
547,956 
558,895 
1.30 (0.76-2.21) 
0.99 (0.51-1.92) 
0.52 
Smoking¶       
• Never smoker 
• Ever smoker 
 104 
 288 
623,266 
765,627 
1.03 (0.49-2.17) 
1.17 (0.75-1.83) 
 0.91 
*Abbreviations: Multivariable (MV), hazard ratio (HR), confidence intervals (CI). ∆ Comparing the extremes of mMED score quartiles. Models 
are adjusted for age (years), cohort (sex), body mass index, smoking (never, past, and current), and total caloric intake. ¶ Missing data was 
not included or imputed for these analyses. 
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Figure 2. HRs for Crohn’s disease and Ulcerative Colitis  
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